Cargando…

Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib

Detalles Bibliográficos
Autores principales:	Zhao, Bin, Zhao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349436/ https://www.ncbi.nlm.nih.gov/pubmed/30719220 http://dx.doi.org/10.18632/oncotarget.26577

Ejemplares similares

Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
por: Zhao, Bin, et al.
Publicado: (2017)

Correction: Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2019)

Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2017)

Correction: Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
por: Grünewald, Sylvia, et al.
Publicado: (2023)

Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab
por: Matsumoto, Toshihiko, et al.
Publicado: (2023)

Incidence and risk of falls in patients treated for hematologic malignancies in the Intensive Hematology Unit
por: Lorca, Luz Alejandra, et al.
Publicado: (2019)

Correction: Total gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatment
por: Chou, Wen-Chi, et al.
Publicado: (2013)

Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
por: Ricci, Vincenzo, et al.
Publicado: (2020)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Correction: Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients
por: Otsuka, Masakazu, et al.
Publicado: (2019)

Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients
por: Schvartsman, Gustavo, et al.
Publicado: (2017)

The Incidence of Hematological Toxicities in Colorectal Cancer Patients Treated With Fluoropyrimidine-Based Regimens at Princess Noorah Oncology Center
por: Khan, Mansoor, et al.
Publicado: (2023)

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
Publicado: (2018)

Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
por: McClung, Michael R., et al.
Publicado: (2018)

Correction: The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004–2009
por: Luo, Jianfeng, et al.
Publicado: (2014)

Correction to: Health risks in international container and bulk cargo transport due to volatile toxic compounds
por: Baur, Xaver, et al.
Publicado: (2018)

Risk of incident diabetes among patients treated with statins: population based study
Publicado: (2013)

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
por: Chamberlain, Florence, et al.
Publicado: (2020)

Correction: External validation of risk prediction models for incident colorectal cancer using UK Biobank
por: Usher-Smith, J. A., et al.
Publicado: (2020)

Correction: Treating the patient and not just the cancer: therapeutic burden in prostate cancer
por: Spratt, Daniel E., et al.
Publicado: (2021)

Correction to: Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020
por: Badar, Farhana, et al.
Publicado: (2023)

Correction to: COVID‑19 infection in pediatric patients treated for cancer
por: Oz-Alcalay, Lital, et al.
Publicado: (2021)

Correction to: Postoperative delirium in critically ill surgical patients: incidence, risk factors, and predictive scores
por: Chaiwat, Onuma, et al.
Publicado: (2019)

Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Early experience of seven hepatocellular carcinoma cases treated with regorafenib
por: Uchikawa, Shinsuke, et al.
Publicado: (2018)

Correction: Evaluation of Acute Toxicity and Early Clinical Outcome in Head and Neck Cancers Treated With Conventional Radiotherapy and Simultaneous Integrated Boost Arc Radiotherapy
por: Bahl, Amit, et al.
Publicado: (2017)

Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
por: Patel, Anuj K., et al.
Publicado: (2019)

Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors
por: Zhao, Xiaoliang, et al.
Publicado: (2019)

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials
por: Alecu, Iulian, et al.
Publicado: (2018)

Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
Publicado: (2022)

Correction: Cancer Incidence following Expansion of HIV Treatment in Botswana
por: Dryden-Peterson, Scott, et al.
Publicado: (2015)

Correction: Cancer in Lahore, Pakistan, 2010–2019: an incidence study
Publicado: (2023)

Correction to: Evaluation of Cardiovascular Disease Risk in HIV‑1–Infected Patients Treated with Darunavir
por: Opsomer, Magda, et al.
Publicado: (2018)

Correction: New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Publicado: (2020)

Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity
por: Hengstler, Jan G., et al.
Publicado: (2021)

Correction: Real-time cell toxicity profiling of Tox21 10K compounds reveals cytotoxicity dependent toxicity pathway linkage
por: Hsieh, Jui-Hua, et al.
Publicado: (2017)

Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives
por: Saeki, Sumito, et al.
Publicado: (2023)

Incidence and risk of cardiac toxicities in patients with relapsed and refractory multiple myeloma treated with carfilzomib
por: Zhao, Fang, et al.
Publicado: (2018)

Correction: Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2
por: Tang, Jiaqi, et al.
Publicado: (2006)

Correction: The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide
por: Zhang, Bao-fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4stcefmeh5ed8dkoue52ro5kgl